Advisors Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192K | Buy |
6,091
+3
| +0% | +$95 | ﹤0.01% | 1120 |
|
|
2025
Q1 | $202K | Buy |
6,088
+2,737
| +82% | +$90.8K | ﹤0.01% | 1108 |
|
|
2024
Q4 | $115K | Sell |
3,351
-12,918
| -79% | -$445K | ﹤0.01% | 1202 |
|
|
2024
Q3 | $651K | Sell |
16,269
-650
| -4% | -$26K | 0.01% | 848 |
|
|
2024
Q2 | $510K | Sell |
16,919
-5,997
| -26% | -$181K | 0.01% | 896 |
|
|
2024
Q1 | $770K | Sell |
22,916
-737
| -3% | -$24.7K | 0.01% | 802 |
|
|
2023
Q4 | $764K | Sell |
23,653
-2,095
| -8% | -$67.7K | 0.02% | 784 |
|
|
2023
Q3 | $844K | Sell |
25,748
-467
| -2% | -$15.3K | 0.02% | 759 |
|
|
2023
Q2 | $923K | Buy |
26,215
+2,817
| +12% | +$99.1K | 0.02% | 766 |
|
|
2023
Q1 | $764K | Buy |
23,398
+2,709
| +13% | +$88.4K | 0.02% | 838 |
|
|
2022
Q4 | $1.14M | Buy |
20,689
+15,361
| +288% | +$846K | 0.02% | 699 |
|
|
2022
Q3 | $236K | Buy |
5,328
+1,074
| +25% | +$47.6K | 0.01% | 1105 |
|
|
2022
Q2 | $207K | Buy |
+4,254
| New | +$207K | ﹤0.01% | 1157 |
|